Jason Chia-Hsien Cheng, MD, PhD, MS, FASTRO

National Taiwan University Hospital

Taipei, Taipei

Disclosures:

Presentations

Sep 30

293 - Patient-Specific TP53-Mutant Circulating Tumor DNA as a Prognostic Biomarker for Detection of Minimal Residual Disease after Neoadjuvant Concurrent Chemoradiotherapy followed by Esophagectomy in Local

08:40am - 08:50am PT